Latin America: Malaria

(asked on 8th September 2022) - View Source

Question to the Foreign, Commonwealth & Development Office:

To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what assessment his Department has made of the potential impact of the development of a Malaria vaccine on health standards in Latin America.


Answered by
Jesse Norman Portrait
Jesse Norman
This question was answered on 23rd September 2022

The UK welcomes progress in the development of vaccines for malaria and applauds the impact of British expertise and innovation. The World Health Organisation (WHO) recommendation in October 2021 for the use of the new Mosquirix (RTS,S) vaccine for the prevention of plasmodium falciparum malaria in children living in Sub Saharan Africa and in other regions with moderate to high transmission is a significant milestone.

Other cost-effective and proven malaria interventions must continue alongside the roll out of any vaccine to ensure high levels of protection against the disease. The UK is committed to tackling malaria, which is closely linked to our ambition to end preventable deaths of mothers, babies and newborns. The UK works with partners such as Gavi, the vaccine alliance, to improve access to life-saving vaccines.

Reticulating Splines